RT Journal Article
SR Electronic
T1 814 Enhancing anti-tumor response in ICI-refractory non-small cell lung cancer through intravenous administration of oncolytic adenovirus armed with hTNFα and hIL-2 in combination with aPD-1 blockade
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A912
OP A912
DO 10.1136/jitc-2023-SITC2023.0814
VO 11
IS Suppl 1
A1 Kudling, Tatiana V
A1 Clubb, James
A1 Pakola, Santeri A
A1 Quixabeira, Dafne Alves
A1 Lähdeniemi, Iris
A1 Heiniö, Camilla
A1 Arias, Victor
A1 Grönberg-Vähä-Koskela, Susanna AM
A1 Havunen, Riikka
A1 Cervera-Carrascon, Victor
A1 Santos, Joao Manuel
A1 Sutinen, Eva
A1 Räsänen, Jari
A1 Borenius, Kristian
A1 Mäyränpää, Mikko
A1 Altonen, Eero
A1 Sorsa, Suvi
A1 Hemminki, Otto
A1 Kanerva, Anna
A1 Verschuren, Emmy W
A1 Ilonen, Ilkka
A1 Hemminki, Akseli
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A912.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.